Skip to main navigation Skip to search Skip to main content

Assessment of safety and efficacy of intravenous remternetug in early symptomatic Alzheimer's disease

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/2412/31/25

Funding

  • Lilly USA LLC: $5,001.00